Mesoblast Total Assets 2012-2019 | MESO

Mesoblast total assets from 2012 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Mesoblast Annual Total Assets
(Millions of US $)
2018 $692
2017 $656
2016 $684
2015 $782
2014 $826
2013 $908
2012 $744
2011 $755
Mesoblast Quarterly Total Assets
(Millions of US $)
Q3 2019 $676
Q2 2018 $688
Q1 2018 $689
Q4 2018 $692
Q3 2018 $678
Q2 2017 $665
Q1 2017 $672
Q4 2017 $656
Q3 2017 $679
Q2 2016 $661
Q1 2016 $665
Q4 2016 $684
Q3 2016 $0
Q2 2015 $791
Q1 2015 $753
Q4 2015 $684
Q2 2014 $0
Q4 2014 $826
Q4 2013 $908
Q4 2012 $744
Q4 2011 $755
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.465B $0.017B
Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast's allogeneic, 'off-the-shelf' cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Celgene (CELG) United States $68.622B 11.63
Illumina (ILMN) United States $51.613B 59.81
Biogen (BIIB) United States $44.941B 8.53
Vertex Pharmaceuticals (VRTX) United States $44.509B 53.80
Regeneron Pharmaceuticals (REGN) United States $33.983B 15.97
Alexion Pharmaceuticals (ALXN) United States $26.940B 15.25
Incyte (INCY) United States $17.550B 71.17
BioMarin Pharmaceutical (BMRN) United States $15.072B 0.00
Exact Sciences (EXAS) United States $14.452B 0.00
Seattle Genetics (SGEN) United States $11.552B 0.00
Array BioPharma (ARRY) United States $10.298B 0.00
Sarepta Therapeutics (SRPT) United States $9.423B 0.00
QIAGEN (QGEN) Netherlands $8.939B 29.36
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.848B 53.55
Guardant Health (GH) United States $7.801B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.617B 0.00
Bluebird Bio (BLUE) United States $6.764B 0.00
Exelixis (EXEL) United States $6.235B 15.89
Amarin (AMRN) Ireland $6.204B 0.00
Galapagos (GLPG) Belgium $6.199B 0.00
Ascendis Pharma (ASND) Denmark $5.393B 0.00
BeiGene (BGNE) Cayman Islands $5.317B 0.00
Moderna (MRNA) United States $5.189B 0.00
Blueprint Medicines (BPMC) United States $4.614B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.051B 0.00
Spark Therapeutics (ONCE) United States $3.829B 0.00
China Biologic Products (CBPO) China $3.666B 23.28
ACADIA Pharmaceuticals (ACAD) United States $3.665B 0.00
Repligen (RGEN) United States $3.660B 91.18
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.500B 0.00
Alkermes (ALKS) Ireland $3.480B 0.00
Allogene Therapeutics (ALLO) United States $3.330B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.113B 0.00
UniQure (QURE) Netherlands $3.067B 0.00
Global Blood Therapeutics (GBT) United States $3.059B 0.00
Arena Pharmaceuticals (ARNA) United States $2.837B 5.76
Amicus Therapeutics (FOLD) United States $2.779B 0.00
Lion Biotechnologies (IOVA) United States $2.711B 0.00
Medicines (MDCO) United States $2.647B 0.00
Reata Pharmaceuticals (RETA) United States $2.551B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.547B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.505B 0.00
Immunomedics (IMMU) United States $2.500B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.490B 0.00
Halozyme Therapeutics (HALO) United States $2.351B 0.00
Emergent Biosolutions (EBS) United States $2.329B 20.23
NeoGenomics (NEO) United States $2.301B 150.63
Akcea Therapeutics (AKCA) United States $2.263B 0.00
MyoKardia (MYOK) United States $2.204B 0.00
Ligand Pharmaceuticals (LGND) United States $2.190B 18.14
Acceleron Pharma (XLRN) United States $2.021B 0.00
Insmed (INSM) United States $1.965B 0.00
Genomic Health (GHDX) United States $1.931B 41.02
REGENXBIO (RGNX) United States $1.884B 0.00
Allakos (ALLK) United States $1.867B 0.00
Denali Therapeutics (DNLI) United States $1.867B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.856B 0.00
Myriad Genetics (MYGN) United States $1.817B 18.07
AnaptysBio (ANAB) United States $1.817B 0.00
Audentes Therapeutics (BOLD) United States $1.765B 0.00
Cambrex (CBM) United States $1.454B 18.38
Nabriva Therapeutics AG (NBRV) Ireland $1.443B 0.00
Innoviva (INVA) United States $1.441B 3.99
Alector (ALEC) United States $1.402B 0.00
Gossamer Bio (GOSS) United States $1.390B 0.00
Apellis Pharmaceuticals (APLS) United States $1.382B 0.00
Coherus BioSciences (CHRS) United States $1.356B 0.00
Aimmune Therapeutics (AIMT) United States $1.284B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.255B 0.00
Fate Therapeutics (FATE) United States $1.246B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.243B 0.00
Eidos Therapeutics (EIDX) United States $1.209B 0.00
Athenex (ATNX) United States $1.194B 0.00
Rubius Therapeutics (RUBY) United States $1.150B 0.00
Epizyme (EPZM) United States $1.128B 0.00
Sangamo Therapeutics (SGMO) United States $1.126B 0.00
Editas Medicine (EDIT) United States $1.113B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.082B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.040B 0.00
CORTEXYME INC (CRTX) United States $1.026B 0.00
Atara Biotherapeutics (ATRA) United States $1.022B 0.00
Codexis (CDXS) United States $0.970B 0.00
RA PHARMCTL INC (RARX) United States $0.962B 0.00
WAVE Life Sciences (WVE) Singapore $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
NGM Biopharmaceuticals (NGM) United States $0.918B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.881B 0.00
ANI Pharmaceuticals (ANIP) United States $0.873B 15.49
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
Principia Biopharma (PRNB) United States $0.841B 0.00
Twist Bioscience (TWST) United States $0.826B 0.00
Retrophin (RTRX) United States $0.822B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.789B 37.25
Cara Therapeutics (CARA) United States $0.789B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.786B 0.00
Intra-Cellular Therapies (ITCI) United States $0.780B 0.00
Axsome Therapeutics (AXSM) United States $0.772B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.771B 0.00
Clovis Oncology (CLVS) United States $0.748B 0.00
Kura Oncology (KURA) United States $0.744B 0.00
G1 THERAPEUTICS (GTHX) United States $0.740B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.731B 0.00
Adverum Biotechnologies (ADVM) United States $0.730B 0.00
Vericel (VCEL) United States $0.725B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.711B 0.00
Arvinas (ARVN) United States $0.709B 0.00
MeiraGTx Holdings (MGTX) United States $0.691B 0.00
Myovant Sciences (MYOV) United Kingdom $0.677B 0.00
Intellia Therapeutics (NTLA) United States $0.671B 0.00
Zymeworks (ZYME) Canada $0.662B 0.00
Stemline Therapeutics (STML) United States $0.655B 0.00
Zealand Pharma (ZEAL) Denmark $0.643B 7.51
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.637B 0.00
Precision BioSciences (DTIL) United States $0.632B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.627B 0.00
Cytokineticsorporated (CYTK) United States $0.621B 0.00
Heska (HSKA) United States $0.610B 62.48
Cellectis (CLLS) France $0.607B 0.00
Viking Therapeutics (VKTX) United States $0.586B 0.00
Anika Therapeutics (ANIK) United States $0.576B 19.67
Puma Biotechnology (PBYI) United States $0.526B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.525B 0.00
Revance Therapeutics (RVNC) United States $0.498B 0.00
Scholar Rock Holding (SRRK) United States $0.494B 0.00
DBV Technologies (DBVT) France $0.492B 0.00
BeyondSpring (BYSI) United States $0.489B 0.00
CytomX Therapeutics (CTMX) United States $0.489B 0.00
UROGEN PHARMA (URGN) United States $0.489B 0.00
Magenta Therapeutics (MGTA) United States $0.460B 0.00
ObsEva SA (OBSV) Switzerland $0.457B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.456B 0.00
Synthorx (THOR) United States $0.450B 0.00
Sorrento Therapeutics (SRNE) United States $0.446B 0.00
Kodiak Sciences (KOD) United States $0.443B 0.00
Provention Bio (PRVB) United States $0.424B 0.00
Krystal Biotech (KRYS) United States $0.415B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.413B 0.00
Replimune (REPL) United States $0.413B 0.00
Kaleido Biosciences (KLDO) $0.412B 0.00
MediciNova (MNOV) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.403B 0.00
UNITY Biotechnology (UBX) $0.393B 0.00
AC Immune SA (ACIU) Switzerland $0.392B 25.22
Prothena (PRTA) Ireland $0.388B 0.00
BioDelivery Sciences (BDSI) United States $0.387B 0.00
Agenus (AGEN) United States $0.387B 0.00
Albireo Pharma (ALBO) United States $0.384B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.378B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Acorda Therapeutics (ACOR) United States $0.370B 6.51
Gritstone Oncology (GRTS) United States $0.368B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
Biofrontera AG Sponsored ADR (BFRA) Germany $0.358B 0.00
Senesco Technologies (ELOX) United States $0.355B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.343B 0.00
ResTORbio (TORC) United States $0.338B 0.00
NEXTCURE INC (NXTC) United States $0.332B 0.00
AVROBIO (AVRO) United States $0.326B 0.00
Kindred Biosciences (KIN) United States $0.320B 0.00
LogicBio Therapeutics (LOGC) United States $0.313B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.305B 0.00
Merus (MRUS) Netherlands $0.302B 0.00
PHASEBIO PHARMA (PHAS) United States $0.301B 0.00
Cyclerion Therapeutics (CYCN) United States $0.295B 0.00
Palatin Technologies (PTN) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Geron (GERN) United States $0.274B 0.00
Athersys (ATHX) United States $0.274B 0.00
Syros Pharmaceuticals (SYRS) United States $0.272B 0.00
Dynavax Technologies (DVAX) United States $0.267B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
XBiotech (XBIT) United States $0.263B 0.00
Chiasma (CHMA) United States $0.257B 0.00
Sutro Biopharma (STRO) United States $0.255B 0.00
Inovio Pharmaceuticals (INO) United States $0.253B 0.00
Constellation Pharmaceuticals (CNST) United States $0.248B 0.00
Urovant Sciences (UROV) United States $0.247B 0.00
Synlogic (SYBX) United States $0.241B 0.00
Evelo Biosciences (EVLO) United States $0.241B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.234B 0.00
Five Prime Therapeutics (FPRX) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Neothetics (EVFM) United States $0.230B 0.00
Celcuity (CELC) United States $0.230B 0.00
AXCELLA HEALTH (AXLA) United States $0.229B 0.00
Kadmon Holdings (KDMN) United States $0.225B 0.00
Kamada (KMDA) Israel $0.221B 8.58
Cerecor (CERC) United States $0.220B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Avid Bioservices (CDMO) United States $0.220B 0.00
ChromaDex (CDXC) United States $0.219B 0.00
Pfenex (PFNX) United States $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
IDEAYA BIOSCI (IDYA) United States $0.213B 0.00
Enochian BioSciences (ENOB) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Cel-Sci (CVM) United States $0.206B 0.00
Enzo Biochem (ENZ) United States $0.204B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.202B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Kala Pharmaceuticals (KALA) United States $0.190B 0.00
Mersana Therapeutics (MRSN) United States $0.187B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.183B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 10.41
Compugen (CGEN) Israel $0.178B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
HOOKIPA PHARMA (HOOK) United States $0.177B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
CorMedix Inc (CRMD) United States $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
OvaScience (MLND) United States $0.170B 0.00
Dyadic (DYAI) United States $0.167B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Cue Biopharma (CUE) United States $0.165B 0.00
Liquidia Technologies (LQDA) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.159B 0.00
Anavex Life Sciences (AVXL) United States $0.158B 0.00
Intec Pharma (NTEC) Israel $0.158B 0.00
Kezar Life Sciences (KZR) United States $0.155B 0.00
APPLIED THERAPT (APLT) United States $0.154B 0.00
BioTime (BTX) United States $0.154B 10.30
Checkpoint Therapeutics (CKPT) United States $0.153B 0.00
Mustang Bio (MBIO) United States $0.152B 0.00
Aduro Biotech (ADRO) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.143B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
TREVI THERAPTCS (TRVI) United States $0.137B 0.00
Celyad SA (CYAD) Belgium $0.133B 0.00
Verastem (VSTM) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.127B 0.00
Axovant Sciences (AXGT) United States $0.126B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
VolitionRX (VNRX) Singapore $0.121B 0.00
Novavax (NVAX) United States $0.120B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Fortress Biotech (FBIO) United States $0.116B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Aptose Biosciences (APTO) Canada $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.106B 0.00
INmune Bio (INMB) United States $0.106B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.105B 0.00
Equillium (EQ) United States $0.104B 0.00
Arbutus Biopharma (ABUS) Canada $0.103B 0.00
NantKwest (NK) United States $0.103B 0.00
Trevena (TRVN) United States $0.103B 0.00
Aptinyx (APTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.101B 0.00
Selecta Biosciences (SELB) United States $0.099B 0.00
Allena Pharmaceuticals (ALNA) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.090B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Unum Therapeutics (UMRX) United States $0.078B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.075B 0.00
Cohbar (CWBR) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Signal Genetics (MGEN) United States $0.073B 0.00
Applied Genetic Technologies (AGTC) United States $0.073B 39.90
VTv Therapeutics (VTVT) United States $0.072B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Cocrystal Pharma (COCP) United States $0.070B 73.33
Orgenesis (ORGS) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Alcobra (ARCT) United States $0.065B 0.00
Hoth Therapeutics (HOTH) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.065B 0.00
VBI Vaccines (VBIV) United States $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
Ophthotech (ISEE) United States $0.052B 0.00
Zosano Pharma (ZSAN) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.049B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
AZURRX BIOPHARM (AZRX) United States $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.031B 0.00
Aytu Bioscience (AYTU) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Bison Capital Acquisition (XYN) China $0.025B 0.00
Histogenics (HSGX) United States $0.023B 0.00
Oragenics (OGEN) United States $0.023B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
GTx (ONCT) United States $0.022B 0.00
Sophiris Bio (SPHS) United States $0.021B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Motif Bio Plc (MTFB) United States $0.012B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Therapix Biosciences (TRPX) Israel $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
IMMURON LTD (IMRN) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (ARMP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00